Current stock page

Financial Data

RVTY Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Diagnostics & ResearchScore data as of Sep 4, 2026

RVTY

Financial Data
Revvity, Inc.
Healthcare· Medical - Diagnostics & Research
AIQ Score
NeutralAIQ Edge 7/10
Low Priority
Above Peers
Score data as of Sep 4, 2026
Last price
$130.22
-$0.41 (-0.31%)
Latest market quote
Momentum81
Value42
Quality50
Risk Resilience64
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 6, 2026.

Income statement
8 periods
Metric2026-07-052026-04-052025-12-282025-09-282025-06-292025-03-302024-12-292024-09-29
Revenue$729.69M$711.12M$772.06M$698.95M$720.28M$664.76M$729.37M$684.05M
Gross Profit$416.87M$387.66M$338.14M$374.6M$392.56M$327.25M$359.69M$384.82M
Operating Income
Net Income$51.82M$40.72M$98.36M$46.65M$55.22M$41.44M$95.04M$93.97M
EPS$0.47$0.36$0.87$0.4$0.47$0.34$0.78$0.77
Cash flow statement
8 periods
Metric2026-07-052026-04-052025-12-282025-09-282025-06-292025-03-302024-12-312024-09-29
Operating Cash Flow$191.94M$115.06M$183.28M$138.58M$134.32M$128.16M$174.23M$147.89M
Capital Expenditure-$11.07M-$19.78M-$20.17M-$18.5M-$18.87M-$15.98M-$24.45M-$22.32M
Free Cash Flow$180.87M$95.28M$163.11M$120.08M$115.45M$112.17M$149.78M$125.57M
Net Cash Provided By Operating Activities$191.94M$115.06M$183.28M$138.58M$134.32M$128.16M$174.23M$147.89M
Balance sheet
8 periods
Metric2026-07-052026-04-052025-12-282025-09-282025-06-292025-03-302024-12-292024-09-29
Total Assets$12.05B$12B$12.17B$12.14B$12.36B$12.36B$12.39B$12.77B
Total Debt$3.34B$3.35B$3.52B$3.37B$3.37B$3.33B$3.33B$3.32B
Cash And Cash Equivalents
Total Liabilities$4.82B$4.81B$4.92B$4.76B$4.81B$4.72B$4.73B$4.85B
Total Stockholders Equity$7.23B$7.18B$7.25B$7.38B$7.56B$7.64B$7.67B$7.92B
Key financial metrics
8 periods
Metric2026-07-052026-04-052025-12-282025-09-282025-06-292025-03-302024-12-292024-09-29
P/E ratio60.0861.3327.9453.1251.4776.6935.6741.74
P/B ratio1.751.381.521.341.51.661.771.98
P/S ratio17.313.8914.2414.1815.7819.1218.5922.94
Debt To Equity0.460.470.480.460.450.440.430.42
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-07-052026-04-052025-12-282025-09-282025-06-292025-03-302024-12-292024-09-29
P/E ratio
P/B ratio1.751.381.521.341.51.661.771.98
P/S ratio17.313.8914.2414.1815.7819.1218.5922.94
Return On Equity0.72%0.57%1.36%0.63%0.73%0.54%1.24%1.19%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
60.28
multipleSep 4, 2026
Pb
1.96
multipleSep 4, 2026
Revenue Growth Yoy
2.61
percentSep 4, 2026
EPS Growth Yoy
30.56
percentSep 4, 2026
Gross Margin
52.11
percentSep 4, 2026
Operating Margin
12.32
percentSep 4, 2026
ROE
3.27
percentSep 4, 2026
ROIC
2.91
percentSep 4, 2026
Debt To Equity
0.46
ratioSep 4, 2026
FCF Yield
3.96
percentSep 4, 2026
Technical indicators
Close
130.22
priceSep 4, 2026
Volume
1,175,228
volumeSep 4, 2026
Rsi14
73.36
indexSep 4, 2026
MACD
4.54
indexSep 4, 2026
MACD Signal
3.85
indexSep 4, 2026
MACD Histogram
0.44
indexSep 4, 2026
Adx14
29.9
indexSep 4, 2026
Sma50
116.4
priceSep 4, 2026
Sma200
102.36
priceSep 4, 2026
Atr14
3.81
priceSep 4, 2026
Historical Volatility
0.3
percentSep 4, 2026
Volume Ma20
1,541,523.55
volumeSep 4, 2026
Risk measures
Resilience Score
64
score_0_100Sep 4, 2026
Beta
1.07
ratioSep 4, 2026
Volatility Annual
37.79
percentSep 4, 2026
Max Drawdown
-30.14
percentSep 4, 2026
Sharpe Ratio
1.2
ratioSep 4, 2026
Var95
-3.56
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

RVTY Financial Data FAQ

What is Revvity, Inc.'s revenue?

Revvity, Inc.'s revenue is one of the core financial data points for RVTY. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Revvity, Inc.'s revenue growing?

Revenue growth shows whether Revvity, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is RVTY's EPS?

RVTY's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Revvity, Inc.'s net income?

Revvity, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Revvity, Inc. generate?

Free cash flow shows how much cash Revvity, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Revvity, Inc. have?

Cash and debt help frame RVTY's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.